- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00441857
Effect of Plant Stanols on Cholesterol Absorption (DOSE)
The Effect of Three Different Stanol Ester Doses in Margarines on Cholesterol Absorption Efficiency
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Serum cholesterol lowering effect of plant sterols is well established and it is also known that plant stanols inhibit the absorption of cholesterol. However, there is lack of dose-response studies directly measuring the cholesterol absorption efficiency during prolonged consumption of plant stanols. Therefore this study aims to measure the cholesterol absorption efficiency at different plant stanol consumption levels using a stable isotope tracer method.
Subjects will be randomized in their study groups that consume 20 g of margarine with different doses of plants stanols (0.8, 1.6 and 2.0g) based on cholesterol absorption efficiency at screening (high and low absorbers randomised separately). Cholesterol absorption test with cholesterol tracer will be conducted twice: at baseline and after 2-3 weeks margarine consumption period.
Cholesterol absorption efficiency will also be examined by indirect method i.e. by following the concentrations of serum cholesterol precursors and plant sterols in blood. In addition serum total, LDL and HDL cholesterol and triglycerides are followed.
Study Type
Enrollment
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Kuopio, Finland, 70210
- Oy Foodfiles Ltd
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy adults with mild to moderate hypercholesterolemia
Exclusion Criteria:
- lipid lowering medication
- pregnancy or lactation
- severe diseases (inc. diabetes, unstable CVD, malignant diseases)
- severe obesity
- regular plant sterol consumption
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
cholesterol absorption efficiency
|
Secondary Outcome Measures
Outcome Measure |
---|
changes in blood lipids
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sakari A Nieminen, MD, Oy Foodfiles Ltd
Study record dates
Study Major Dates
Study Start
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DOSE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypercholesterolemia
-
National Medical Research Center for Therapy and...Moscow State University of Medicine and DentistryRecruitingMedication Adherence | Adherence, Medication | Treatment Adherence | Familial Hypercholesterolemia | Motivational Interviewing | Adherence, Patient | Treatment Adherence and Compliance | Patient Compliance | Adherence | Hypercholesterolemia, Familial | Patient Adherence | Hypercholesterolemia, Autosomal Dominant and other conditionsRussian Federation
-
Direct PlantesUnknownHYPERCHOLESTEROLEMIAFrance
-
Chong Kun Dang PharmaceuticalRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Addpharma Inc.CompletedPrimary HypercholesterolemiaKorea, Republic of
-
JW PharmaceuticalCompletedPrimary HypercholesterolemiaKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedPrimary HypercholesterolemiaKorea, Republic of
-
Provident Clinical ResearchGlaxoSmithKlineUnknownPrimary HypercholesterolemiaUnited States
-
Organon and CoCompletedPrimary Hypercholesterolemia | Homozygous Familial Hypercholesterolemia
-
Merck Sharp & Dohme LLCTerminated
-
Danone JapanCompletedHealthy | Mild HypercholesterolemiaJapan
Clinical Trials on plant stanol consumption
-
Maastricht University Medical CenterRaisio Nutrition Ltd.Completed
-
University of HelsinkiUniversity of Eastern FinlandCompleted
-
Yonsei UniversityCompletedLDL-cholesterol Level 130-159mg/dL
-
Clinical Life Sciences Ltd.Completed
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompleted
-
Raisio GroupActive, not recruitingHypercholesterolemiaFinland
-
University of HelsinkiFinnish Institute of Occupational HealthCompleted
-
Raisio GroupMedfiles Ltd., FinlandCompletedDyslipidemias | Hypercholesterolemia | Hyperlipidemias
-
Raisio GroupIndonesia UniversityCompletedDyslipidemias | Hypercholesterolemia | Hyperlipidemias
-
Raisio GroupClinical Research Institute HUCH LtdCompletedDyslipidemias | Hypercholesterolemia | Hyperlipidemias